<DOC>
	<DOC>NCT01906164</DOC>
	<brief_summary>This study will assess the safety, tolerability, and pharmacokinetics (PK) of orally administered ALS-008176 in healthy volunteers.</brief_summary>
	<brief_title>Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>Male or female subjects, 1855 years of age, in good health with screening laboratory values within limits specified by the protocol Body mass index 1830 kg/m2 Female subjects must be of nonchildbearing potential; male subjects must be surgically sterile or practicing birth control Clinically significant or uncontrolled medical illness Use, or anticipated use during conduct of the study, of concomitant medications</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>RSV</keyword>
</DOC>